Rhinology Future Debates 2018, a EUFOREA Report.


Journal

Rhinology
ISSN: 0300-0729
Titre abrégé: Rhinology
Pays: Netherlands
ID NLM: 0347242

Informations de publication

Date de publication:
01 Aug 2020
Historique:
pubmed: 26 4 2020
medline: 1 12 2020
entrez: 26 4 2020
Statut: ppublish

Résumé

The third Rhinology Future Debates was organized by the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) in 2018 in Brussels. Experts from different specialties and countries, alongside patients, health policy makers and industry representatives discussed relevant topics in Rhinology, in an attempt to improve current clinical practices, through implementation of precision medicine, by empowering patients' participation and the use of eHealth tools. The debates which are available on-line (www.rhinology-future.com) dealt with 5 topics in Rhinology: the adoption of allergen-specific immunotherapy (AIT) by implementing change management strategies, the needs and obstacles in care delivery in respiratory diseases, 3D technology in nose and sinus surgery, ambulatory nasal surgery, and clinical evidence for efficacy of biologicals in CRSwNP and asthma. This report summarizes the outcomes of the brainstorming sessions highlighting novel approaches and unmet needs in the field of respiratory diseases by focusing on integrated care pathways.

Identifiants

pubmed: 32333751
pii: 2460
doi: 10.4193/Rhin19.455
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

384-393

Auteurs

E Prokopakis (E)

Department of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Crete, Greece.

A Vardouniotis (A)

ENT Department, St Mary's Treatment Centre, Portsmouth, UK.

C Bachert (C)

Ghent University Hospital, Ghent, Belgium.

J Bousquet (J)

University Hospital, Montpellier, MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France.

S Carrie (S)

ENT Department, Newcastle upon Tyne NHS Hospitals FT, Newcastle upon Tyne, UK.

P Castelnuevo (P)

Department of Otorhinolaryngology, University of Insubria and ASST Sette Laghi, Ospedale di Circolo, Varese, Italy.

J Constantinidis (J)

1st Department of Otorhinolaryngology, Head and Neck Surgery, AHEPA Hospital, Aristotle University of Thessaloniki, Greece.

W Fokkens (W)

Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.

C Hopkins (C)

ENT Department, Guy's and St Thomas' Hospital, London, UK.

A Leunig (A)

Rhinology Center, ENT-Clinic Bogenhausen, Dr. Gaertner GmbH, Munich, Germany.

G Molteni (G)

Otorhinolaryngology-Head and Neck Surgery Department, University Hospital of Verona, Verona, Italy.

J Mullol (J)

Clinical and Experimental Respiratory Immunoallergy, Hospital ClÃ-nic, IDIBAPS, Barcelona, Spain.

G Scadding (G)

The Royal National Throat Nose and Ear Hospital, London, UK.

G Marien (G)

European Forum for Research and Education in allergy and Airway Diseases (EUFOREA), Brussels, Belgium.

M Doulaptsi (M)

Department of Otorhinolaryngology-Head and Neck Surgery, University of Crete School of Medicine, Heraklion, Crete, Greece.

P Hellings (P)

Ghent University Hospital, Ghent, Belgium; 1st Department of Otorhinolaryngology, Head and Neck Surgery, AHEPA Hospital, Aristotle University of Thessaloniki, Greece; Clinical Division of Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH